Oncimmune Holdings plc announced that further to the announcement made on 7 December 2022, John Goold has been appointed to the Board of the Company as Non-Executive Director with immediate effect, following the successful completion of customary due diligence checks by the Company's Nominated Adviser. Additional Information in respect of the AIM Rules: The following information regarding the appointment of John Howard Goold, aged 51, is disclosed under Schedule 2(g) of the AIM Rules for Companies.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.45 GBX | -0.48% |
|
+7.18% | -58.53% |
05-21 | EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss | AN |
05-21 | Earnings Flash (ONC.L) ONCIMMUNE HOLDINGS Posts Fiscal H1 Revenue GBP1.2M | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.53% | 10.1M | |
+6.87% | 72.01B | |
+33.97% | 10.39B | |
+40.84% | 5.26B | |
-18.53% | 4.64B | |
+12.65% | 3.7B | |
+27.58% | 2.3B | |
-39.96% | 1.8B | |
-45.87% | 1.7B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ONC Stock
- News Oncimmune Holdings plc
- Oncimmune Holdings plc Announces Appointment of John Goold as Non-Executive Director